Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Biological Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12639965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thimerosal stimulates focal adhesion kinase and cytoskeletal changes by redox modulation.

  2002cited by this paper
• Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.

  2002cited by this paper
• Clinical translation of angiogenesis inhibitors

  2002cited by this paper
• Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange.

  2002cited by this paper
• Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-deoxy-D-ribose.

  2002cited by this paper
• The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells

  2002cited by this paper
• Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins.

  2001cited by this paper
• Integrin signaling revisited.

  2001cited by this paper
• Adhesion events in angiogenesis.

  2001cited by this paper
• Mechanism of integrin activation by disulfide bond reduction.

  2001cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

  2000cited by this paper
• Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin.

  2000cited by this paper
• Focal Adhesion Kinase: a regulator of focal adhesion dynamics and cell movement

  2000cited by this paper
• Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A.

  2000cited by this paper
• v-Src Induces Tyrosine Phosphorylation of Focal Adhesion Kinase Independently of Tyrosine 397 and Formation of a Complex with Src*

  2000cited by this paper
• Signaling through focal adhesion kinase.

  1999cited by this paper
• Integrin signaling.

  1999cited by this paper
• Inhibition of Endothelial Cell Migration, Intercellular Communication, and Vascular Tube Formation by Thromboxane A2 *

  1999cited by this paper
• Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor‐2

  1999cited by this paper
• The highly reducing sugar 2-deoxy-D-ribose induces apoptosis in human fibroblasts by reduced glutathione depletion and cytoskeletal disruption.

  1998cited by this paper
• Bombesin, Vasopressin, Lysophosphatidic Acid, and Sphingosylphosphorylcholine Induce Focal Adhesion Kinase Activation in Intact Swiss 3T3 Cells*

  1998cited by this paper
• Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.

  1998cited by this paper
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins.

  1998cited by this paper
• The αvβ3 Integrin Regulates α5β1-mediated Cell Migration toward Fibronectin*

  1997cited by this paper
• Mesodermal defects and cranial neural crest apoptosis in alpha5 integrin-null embryos.

  1997cited by this paper
• Signaling through focal adhesion kinase

  1997cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Cell migration: a physically integrated molecular process.

  1996cited by this paper
• Moving membrane up to the front of migrating cells.

  1996cited by this paper
• Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma.

  1996cited by this paper
• Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells.

  1996cited by this paper
• Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma.

  1996cited by this paper
• Focal adhesions, contractility, and signaling.

  1996cited by this paper
• Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases

  1995cited by this paper
• Thymidine phosphorylase is angiogenic and promotes tumor growth.

  1995cited by this paper
• Integrin beta 3 cytoplasmic tail is necessary and sufficient for regulation of alpha 5 beta 1 phagocytosis by alpha v beta 3 and integrin-associated protein

  1995cited by this paper
• Definition of two angiogenic pathways by distinct alpha v integrins.

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization.

  1995cited by this paper
• Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1).

  1994cited by this paper
• Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.

  1994cited by this paper
• Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1

  1994cited by this paper
• Requirement of vascular integrin alpha v beta 3 for angiogenesis.

  1994cited by this paper
• Angiogenic activity of enzymes

  1994cited by this paper
• Pyrimidine nucleotide metabolism in human colon carcinomas: Comparison of normal tissues, primary tumors and xenografts

  1994cited by this paper
• High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

  1993cited by this paper
• Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity.

  1993cited by this paper
• Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor.

  1993cited by this paper
• Embryonic mesodermal defects in alpha 5 integrin-deficient mice.

  1993cited by this paper
• Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin.

  1993cited by this paper
• Integrins: versatility, modulation, and signaling in cell adhesion.

  1992cited by this paper
• Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity.

  1992cited by this paper
• Angiogenic factor

  1992cited by this paper
• pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.

  1992cited by this paper
• Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor

  1989cited by this paper
• Endothelial cells use alpha 2 beta 1 integrin as a laminin receptor

  1989cited by this paper
• Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor.

  1985cited by this paper
• Identification of the ribose binding protein as the receptor for ribose chemotaxis in Salmonella typhimurium.

  1974cited by this paper

• Thymidine phosphorylase in nucleotide metabolism: physiological functions and its implications in tumorigenesis and anti-cancer therapy

  2025cites this paper
• Unravelling Thymidine phosphorylase: Mechanisms and multifunctional impact on cardiovascular system - from bench to bedside.

  2025cites this paper
• Thymidine Phosphorylase Promotes the Formation of Abdominal Aortic Aneurysm in Mice Fed a Western Diet

  2024cites this paper
• Thymidine Phosphorylase Promotes Abdominal Aortic Aneurysm via VSMC Modulation and Matrix Remodeling in Mice and Humans

  2024cites this paper
• Distinctive metabolic remodeling in TYMP deficiency beyond mitochondrial dysfunction

  2023cites this paper
• Investigating DNA Methylation of Solute Carrier Genes in Colorectal Cancer: A Comprehensive Analysis Using Microarray and Bioinformatics Tools

  2023cites this paper
• Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma

  2023cites this paper
• Identifying Potential New Gene Expression-Based Biomarkers in the Peripheral Blood Mononuclear Cells of Hepatitis B-Related Hepatocellular Carcinoma

  2022cites this paper
• Recent advances in the synthetic thymidine phosphorylase inhibitors for cancer therapy.

  2022cites this paper
• Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in vitro

  2021cites this paper
• Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells <Italic>in </Italic><Italic>vitro</Italic>

  2021cites this paper
• Design, Synthesis, and In Vitro Antiproliferative Activity of Hydantoin and Purine Derivatives with the 4-Acetylphenylpiperazinylalkyl Moiety

  2021cites this paper
• SLPI is a critical mediator that controls PTH-induced bone formation

  2021cites this paper
• TAS-102 – a new option in the treatment of patients with advanced colorectal cancer after failure or intolerance to other therapies

  2020cites this paper
• Thymidine phosphorylase promotes angiogenesis and tumour growth in intrahepatic cholangiocarcinoma.

  2020cites this paper
• Antimalarial Drug Pyrimethamine Plays a Dual Role in Antitumor Proliferation and Metastasis through Targeting DHFR and TP

  2019cites this paper
• Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs.

  2019cites this paper
• Thymidine phosphorylase in cancer aggressiveness and chemoresistance

  2018cites this paper
• Thymidine phosphorylase: A potential new target for treating cardiovascular disease.

  2017cites this paper
• Thymidine Catabolism as a Metabolic Strategy for Cancer Survival.

  2017cites this paper
• New targets in tumor angiogenesis to block tumor re-growth and therapeutic resistance

  2017cites this paper
• Trifluridine/Tipiracil (Lonsurf) for the Treatment of Metastatic Colorectal Cancer.

  2016cites this paper
• A novel antimetabolite: TAS-102 for metastatic colorectal cancer

  2016cites this paper
• Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer.

  2016cites this paper
• Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.

  2015cites this paper
• TAS-102, a novel antitumor agent: a review of the mechanism of action.

  2015cites this paper
• Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies

  2015cites this paper
• Thymidine Phosphorylase Participates in Platelet Signaling and Promotes Thrombosis

  2014cites this paper
• Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis

  2014cites this paper
• P2Y2 nucleotide receptor activation enhances the aggregation and self-organization of dispersed salivary epithelial cells.

  2014cites this paper
• DNA synthesis inhibitors for the treatment of gastrointestinal cancer

  2014cites this paper
• The kinetic mechanism of Human Thymidine Phosphorylase - a molecular target for cancer drug development.

  2014cites this paper
• Regulation and Novel Action of Thymidine Phosphorylase in Non-Small Cell Lung Cancer: Crosstalk with Nrf2 and HO-1

  2014cites this paper
• TRAIL-induced kinases activation and apoptosis: towards improved death receptor targeted therapy for lung cancer

  2013cites this paper
• Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate

  2013cites this paper
• Thymidine phosphorylase enhances reactive oxygen species generation and interleukin-8 expression in human cancer cells.

  2012cites this paper
• Fluorophosphonylated nucleoside derivatives as new series of thymidine phosphorylase multisubstrate inhibitors.

  2012cites this paper
• TAS-102: more than an antimetabolite.

  2012cites this paper
• Redefining endothelial progenitor cells using a proteomics approach

  2012cites this paper
• Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli

  2012cites this paper
• The Thymidine Phosphorylase Inhibitor 5′-O-Tritylinosine (KIN59) Is an Antiangiogenic Multitarget Fibroblast Growth Factor-2 Antagonist

  2012cites this paper
• Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells.

  2011cites this paper
• Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors

  2011influential citation
• Proteomics: a reality-check for putative stem cells.

  2011cites this paper
• A Reality-Check for Putative Stem Cells

  2011cites this paper
• Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase.

  2011cites this paper
• Deoxyribose Protects Against Rapamycin-Induced Cytotoxicity in Colorectal Cancer Cells In Vitro

  2011influential citation
• Increased Migration by Stimulation of Thymidine Phosphorylase in Endothelial Cells of Different Origin

  2010cites this paper
• Paracrine Stimulation of Endothelial Cell Motility and Angiogenesis by Platelet-Derived Deoxyribose-1-Phosphate

  2010cites this paper
• Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells.

  2010cites this paper
• Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma.

  2010cites this paper
• Accumulation of thymidine-derived sugars in thymidine phosphorylase overexpressing cells.

  2010cites this paper
• Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by increasing the secretion of angiogenic factors

  2010cites this paper
• The role of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor behavior Nucleosides Nucleotides and Nucleic acids 27 : 681-91 , 2008

  2010cites this paper
• Antiangiogenic and Antitumor Activity of 6-(2-Aminoethyl)Amino-5-Chlorouracil, a Novel Small-Molecule Inhibitor of Thymidine Phosphorylase, in Combination with the Vascular Endothelial Growth Factor-Trap

  2009cites this paper
• 2-Deoxy-D-ribose, a downstream mediator of thymidine phosphorylase, regulates tumor angiogenesis and progression.

  2009cites this paper
• Rôle de la fibrilline-1 dans la fonction cardiovasculaire au cours du vieillissement : signalisation de la fibrilline-1 dans les cellules endothéliales humaines et exploration structurale et fonctionnelle chez les souris Fbn-1+/mgΔ.

  2009cites this paper
• The dual role of thymidine phosphorylase in cancer development and chemotherapy

  2009cites this paper
• Adenocarcinoma Cancer Cell Invasion Activity in Patients with Gastric Angiogenic Factor Thymidine Phosphorylase Increases

  2008cites this paper
• The Role of Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Tumor Behavior

  2008influential citation
• Nucleosides, Nucleotides and Nucleic Acids

  2008cites this paper
• Angiogenic Factor Thymidine Phosphorylase Increases Cancer Cell Invasion Activity in Patients with Gastric Adenocarcinoma

  2008cites this paper
• Targeting matrix metalloproteinases and endothelial cells with a fusion peptide against tumor.

  2007cites this paper
• Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.

  2007cites this paper
• Clarithromycin Suppresses Invasiveness of Human Lung Adenocarcinoma Cells

  2007cites this paper
• Targeting vascular cell migration as a strategy for blocking angiogenesis: the central role of focal adhesion protein tyrosine kinase family.

  2007cites this paper
• The Microtubule Binding Drug Laulimalide Inhibits Vascular Endothelial Growth Factor-Induced Human Endothelial Cell Migration and Is Synergistic when Combined with Docetaxel (Taxotere)

  2006cites this paper
• Integrins in drug targeting-RGD templates in toxins.

  2006cites this paper
• 5′-O-Tritylated Nucleoside Derivatives: Inhibition of Thymidine Phosphorylase and Angiogenesis

  2006cites this paper
• 2‐Deoxy‐L‐ribose inhibits the invasion of thymidine phosphorylase‐overexpressing tumors by suppressing matrix metalloproteinase‐9

  2006cites this paper
• Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment.

  2005cites this paper
• Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents.

  2005cites this paper
• Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration

  2005cites this paper
• TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen.

  2005cites this paper
• Nucleophilic participation in the transition state for human thymidine phosphorylase.

  2004cites this paper
• Thromboxane A2 Receptor Signaling Inhibits Vascular Endothelial Growth Factor–Induced Endothelial Cell Differentiation and Migration

  2004cites this paper
• The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression

  2004cites this paper
• Inhibition of Metastasis of Tumor Cells Overexpressing Thymidine Phosphorylase by 2-Deoxy-l-Ribose

  2004cites this paper
• The Nucleoside Derivative 5′-O-Trityl-inosine (KIN59) Suppresses Thymidine Phosphorylase-triggered Angiogenesis via a Noncompetitive Mechanism of Action*

  2004cites this paper